Category: New products
-

Small Biz Grant Funds Mental Health App Clinical Trial
National Institute of Mental Health is funding a clinical trial to evaluate a home-based mobile app that works online with a clinician to treat depression.
-

AI-Aided Collaboration to Discover Neuro Disease Drugs
Two biotechnology and health technology companies are discovering precision treatments for neurological disorders with simulation models for individual patients.
-

Virtual Reality Studied for Chronic Cancer Pain
A software company is partnering with a psychologist to explore virtual reality working with mindfulness for relieving pain in cancer patients.
-

Partnership Developing Faster, Sensitive Covid-19 Test
A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test.
-

AI-Aided Cancer Analytics Gain $21.5M in Early Funds
A start-up enterprise using artificial intelligence algorithms to analyze tumor biopsy images is raising $21.5 million in seed and first-round venture funding.
-

Hydrogel Shown to Boost Beneficial Gut Microbes
Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health.
-

Semiconductor Tech Drug Discovery Company Underway
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds.
-

Trial Begins for Skin-Implanted Addiction Therapy
A clinical trial is underway testing a therapy for opioid use disorder that places a treatment drug pellet under the skin lasting for 12 weeks.
-

State Grant Funds Virus-Immunotherapy Cancer Trial
A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers.
-

Early Trials Show Responses for Some Blood Cancers
First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers.